There are reports in which the briefly increasing effects of basophils are described after the beginning of a treatment with the IgE‐blocking monoclonal antibody omalizumab in patients with chronic spontaneous urticaria (CSU).60, 61, 62. The gene discussed is IGHE; the disease is chronic idiopathic urticaria.